South Africa's Aspen plans to buy infant nutritional business from Nestle
JOHANNESBURG (Reuters) - South Africa's Aspen Pharmacare (APNJ.J) has plans to buy Nestle South Africa's infant nutritional business for $215 million, the company said on Thursday.
The deal gives it certain rights to intellectual property licenses, net assets and shares currently conducted by Pfizer.
(Reporting by Sherilee Lakmidas)
(The story corrects value of acquisition)
BOSTON - Hedge fund manager William Ackman, who is betting $1.16 billion that Herbalife is a fraud, spent $264,000 last year on lobbyists to press his case against the company, according to government documents filed in recent weeks.
- U.S. small businesses borrowed more money in January than they did a year earlier, signaling continued growth in the economy despite a spate of cold weather that has been blamed for weakness in many other indicators of activity.
BEIJING/HONG KONG - China reiterated its opposition on Thursday to a European Union plan to limit airline carbon dioxide emissions and called for talks to resolve the issue a day after its major airlines refused to pay any carbon costs under the new law.